GB1452868A - Propiophenone derivatives and preparation thereof - Google Patents

Propiophenone derivatives and preparation thereof

Info

Publication number
GB1452868A
GB1452868A GB5392474A GB5392474A GB1452868A GB 1452868 A GB1452868 A GB 1452868A GB 5392474 A GB5392474 A GB 5392474A GB 5392474 A GB5392474 A GB 5392474A GB 1452868 A GB1452868 A GB 1452868A
Authority
GB
United Kingdom
Prior art keywords
cerebral
spinal
dec
alkyl
title compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB5392474A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eisai Co Ltd
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Publication of GB1452868A publication Critical patent/GB1452868A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/10—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms
    • C07D295/104—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms with the ring nitrogen atoms and the doubly bound oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/108—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms with the ring nitrogen atoms and the doubly bound oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
GB5392474A 1973-12-14 1974-12-13 Propiophenone derivatives and preparation thereof Expired GB1452868A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP13880873A JPS5527914B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1973-12-14 1973-12-14

Publications (1)

Publication Number Publication Date
GB1452868A true GB1452868A (en) 1976-10-20

Family

ID=15230709

Family Applications (1)

Application Number Title Priority Date Filing Date
GB5392474A Expired GB1452868A (en) 1973-12-14 1974-12-13 Propiophenone derivatives and preparation thereof

Country Status (4)

Country Link
JP (1) JPS5527914B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE2458638C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR (1) FR2254341B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GB (1) GB1452868A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0004000A1 (en) * 1978-02-22 1979-09-19 Nippon Zoki Pharmaceutical Co. Ltd. New propanone derivatives, process for producing thereof and pharmaceutical compositions containing these derivatives as active ingredients
EP0040744A1 (de) * 1980-05-22 1981-12-02 Bayer Ag Aminopropiophenon-oxime, Verfahren zu ihrer Herstellung und ihre Verwendung als Fungizide
EP1514545A1 (de) * 2003-09-11 2005-03-16 Heinl, Alexander, Dr. med. Verwendung von Tolperison zur Behandlung von Spasmen von Organen, die im wesentlichen aus glatter Muskulatur aufgebaut sind.

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1574894A (en) * 1977-06-02 1980-09-10 Nippon Kayaku Kk Derivative of a-methyl-aminopropiophenone and use thereof
JPS5944371A (ja) * 1982-09-07 1984-03-12 Dainippon Pharmaceut Co Ltd １―フエニル―２―メチル―３―（１―ピロリジニル）―１―プロパノン誘導体
HU33131A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * 1984-01-26 1984-10-29
JPH03115267A (ja) * 1989-09-28 1991-05-16 Maruho Kk プロピオフエノン誘導体、その製造方法、それを含む中枢性筋弛緩剤および抗痙攣剤
DE10123129A1 (de) * 2001-05-02 2002-11-14 Berolina Drug Dev Ab Svedala Deuterierte 3-Piperidinopropiophenone sowie diese Verbindungen enthaltende Arzneimittel
DE102005014080B4 (de) * 2005-03-21 2007-11-22 Birds Pharma Gmbh Berolina Innovative Research & Development Services Additionssalze des Tolperison, Verfahren zu deren Herstellung, Verwendung derselben und diese enthaltende Arzneimittel

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0004000A1 (en) * 1978-02-22 1979-09-19 Nippon Zoki Pharmaceutical Co. Ltd. New propanone derivatives, process for producing thereof and pharmaceutical compositions containing these derivatives as active ingredients
EP0040744A1 (de) * 1980-05-22 1981-12-02 Bayer Ag Aminopropiophenon-oxime, Verfahren zu ihrer Herstellung und ihre Verwendung als Fungizide
EP1514545A1 (de) * 2003-09-11 2005-03-16 Heinl, Alexander, Dr. med. Verwendung von Tolperison zur Behandlung von Spasmen von Organen, die im wesentlichen aus glatter Muskulatur aufgebaut sind.

Also Published As

Publication number Publication date
DE2458638C2 (de) 1984-05-10
JPS5089374A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1975-07-17
FR2254341A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1975-07-11
FR2254341B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1979-09-28
DE2458638A1 (de) 1975-06-19
JPS5527914B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1980-07-24

Similar Documents

Publication Publication Date Title
DE19844547C2 (de) Polycyclische Dihydrothiazole, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
EP0022958A1 (de) Harnstoffderivate zur Verwendung bei der Behandlung von Fettstoffwechselstörungen
BE902213A (fr) Composes de phenethanolamine.
EP1259498B1 (de) 8,8a-dihydro-indeno [1,2-d]thiazol-derivate, die in 8a-stellung substituiert sind, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel z.b. als anorektika
DE69330926T2 (de) Isoxazolderivate zur Behandlung von Darmreizungssyndromen
FR2378747A1 (fr) Nouveaux composes d'addition d'un derive de dipeptide et d'un derive d'amino-acide, et leur procede de preparation et de decomposition
GB1452868A (en) Propiophenone derivatives and preparation thereof
DE3687990T2 (de) Hydroxyphenylthioalkylketone.
EP1261593A1 (de) 8,8a-dihydro-indeno 1,2-d]thiazol-derivate, die in 2-stellung einen substituenten mit einer sulfonamidstruktur oder sulfonstruktur tragen; verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
FR2380300A1 (fr) Steroides-11b-substitues et procede de leur preparation
DE3010752A1 (de) Substituierte aethanolamine
DE60209806T2 (de) 2-amino-thiazolinderivate und ihre verwendung als hemmstoffe der induzierbaren no-synthase
DE3884858T2 (de) Phenol-thioalkylamide als Inhibitoren von 5-Lipoxygenase.
West et al. Controlled trial of meprobamate
WO2000051602A1 (de) Verwendung von polycyclischen 2-amino-thiazol systemen zur herstellung von medikamenten zur prophylaxe oder behandlung von obesitas
FR2403334A1 (fr) 5-substitue-10,11-dihydro-5h-dibenzo (a,d) cyclohepten-5,10-imines utile comme medicament
EP0149818A2 (de) Neue 1,4-Naphthochinonderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE3888394T2 (de) Phenolische Thioäther, Sulfoxide und Disulfide als Hemmstoffe der 5-Lipoxigenase.
US4031216A (en) 3-(3,4-Dialkoxy-benzyl)-3-methyl-piperazines
US3772276A (en) As-triazines
EP0030343B1 (de) Substituierte 2-Amino-3,4-dihydropyridinderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
CA1332057C (en) Bicycloalkyl, tricycloalkyl, azabicycloalkyl and azatricycloalkyl amides
GB2192002A (en) Glycine derivatives
DE69509621T2 (de) Diarylheptanoidderivat und diese enthaltende pharmazeutische Zusammensetzung
EP0147778A2 (de) 1,4-Naphthochinonderivate mit entzündungshemmender Wirkung

Legal Events

Date Code Title Description
PS Patent sealed
PE20 Patent expired after termination of 20 years

Effective date: 19941212